NOUGUES MAXIMO F (Chief Financial Officer) sold 4.5% of their position (9.52K shares) of PUMA BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $33.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/10/2025ACC: 0001437749-25-022551
Officer· Chief Financial Officer
Since Nov 2018
-9.52K
Net shares
Net seller
$33.6K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
9.52K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−5.59K
Price / share
$3.53
Trade value
$19.74K
% of position
2.6%
7/8/2025
213.75K→208.16K
Common Stock
Direct
Shares
−3.94K
Price / share
$3.54
Trade value
$13.91K
% of position
1.9%
7/9/2025
208.16K→204.23K
Total
Net shares
−9.52K
Net value
-$33.65K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/8/2025 | S · Sale | −5.59K | $3.53 | $19.74K | 2.6% | 213.75K | 208.16K |
| Common Stock Direct | 7/9/2025 | S · Sale | −3.94K | $3.54 | $13.91K | 1.9% | 208.16K | 204.23K |
| Total | −9.52K | -$33.65K | ||||||
Derivative Transactions0
No derivative transactions reported